Immunosuppressive drugs used in clinical renal transplantation.
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004322:Drainage; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000187:drug effects; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use*; D011878:Radiotherapy; D012712:Serum Globulins / Q000276:immunology; D013156:Splenectomy; D013601:T-Lymphocytes / Q000276:immunology; D013897:Thoracic Duct / Q000503:physiopathology; D013934:Thymectomy; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D012712:Serum Globulins; D003609:Dactinomycin; D003520:Cyclophosphamide; D006493:Heparin; D001379:Azathioprine; D011241:Prednisone